<DOC>
	<DOCNO>NCT02084420</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety H.pylori eradiation effect Ilaprazole Pantoprazole triple therapy 7 day treatment Gastric and/or Duodenal ulcer patient H.pylori positive infection .</brief_summary>
	<brief_title>Efficacy/Safety Study H. Pylori Eradication Triple Therapy 7 Days Treatment</brief_title>
	<detailed_description>This study evaluate efficacy safety H.pylori eradiation effect Ilaprazole Pantoprazole triple therapy 7 day treatment Gastric and/or Duodenal ulcer patient H.pylori positive infection .</detailed_description>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>18 year old â‰¤ Male female &lt; 75 year old Patients endoscopically confirm Gastric and/or duodenal ulcer H.pylori infection confirm Urea Breath Test Patients understand study condition Patients give explanation study , provide voluntary write informed consent participate stud Patients know allergy hypersensitivity reaction Investigational product Patients use Investigational product Patients undergone H.pylori eradication Patients abnormal laboratory result , specify : Total bilirubin , creatinine &gt; 1.5 x upper limit normal Aspartate transminase , Alanine transminase , Alkaline phosphatase , Blood urea nitrogen &gt; 2 x upper limit normal Patients use Proton Pump Inhibitor agent antibiotic within last 2 week start Investigational product Pregnant woman lactate woman Women childbearing potential use medically acceptable method contraception study period . ( Menopausal woman menstrual period least 12 month consider infertile ) Patients uncontrolled Diabetes mellitus Patients uncontrolled Hypertension Patients Alcoholics Patients history malignancy within 5 year prior study entry ( Day 1 ) ( except basal cell carcinoma skin ) Patients undergone esophageal gastric surgery Patients hereditary disorder galactose intolerance , lactose intolerance , glucosegalactose malabsorption Patients participate investigational study within 30 day study entry ( Day 1 ) Patients , investigator 's opinion , suitable study reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>